Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-24-002661
Filing Date
2024-03-28
Accepted
2024-03-28 16:30:24
Documents
2

Document Format Files

Seq Description Document Type Size
1 LENZ THERAPEUTICS, INC. p24-1278sc13g.htm SC 13G 82052
2 JOINT FILING AGREEMENT p24-1278exhibit99.htm EX-99.1 7343
  Complete submission text file 0000902664-24-002661.txt   91176
Mailing Address 445 MARINE VIEW AVE SUITE 320 DEL MAR CA 92014
Business Address 445 MARINE VIEW AVE SUITE 320 DEL MAR CA 92014 858-925-7000
LENZ Therapeutics, Inc. (Subject) CIK: 0001815776 (see all company filings)

EIN.: 844867570 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92660 | Film No.: 24799562
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 667 MADISON AVE. 19TH FLOOR NEW YORK NY 10065
Business Address 667 MADISON AVE. 19TH FLOOR NEW YORK NY 10065 212 803-9080
Alpha Wave Ventures GP, Ltd (Filed by) CIK: 0002007422 (see all company filings)

EIN.: 981624237 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G